ABUSE AND DEPENDENCE
See full prescribing information for complete boxed warning.
- TRADE NAME: Vyvanse (Shire)
- INDICATIONS: Attention-deficit hyperactivity disorder (ADHD)
- CLASS: Anti-attention deficit hyperactivity disorder (anti-ADHD), CNS stimulant, Dextroamphetamine prodrug
- HALF-LIFE: 1 hour
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acetazolamide, Ammonium chloride, Analgesics, Antacids, Antihistamines, Antihypertensives, Antipsychotics, Atomoxetine, Cannabinoids, Carbonic anhydrase inhibitors, Chlorpromazine, Epinephrine, Ethosuximide, Haloperidol, Iobenguane, Lithium, MAO inhibitors, Meperidine, Methenamine, Phenobarbital, Phenytoin, Propoxyphene, Sympathomimetics, Tricyclic antidepressants, Urinary alkalinizing agents
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
